# EDGAR Filing Document

**Accession Number:** 0002044725
**File Stem:** 0000000000-26-004089
**Filing Date:** 2026-4
**Character Count:** 2058
**Document Hash:** dc3898815b0040369ebf9507f3814bd6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-004089.hdr.sgml**: 20260522

**ACCESSION NUMBER**: 0000000000-26-004089

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260422

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Evommune, Inc.
- **CENTRAL INDEX KEY:** 0002044725
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 850742575
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-295140

**BUSINESS ADDRESS:**
- **STREET 1:** 1891 PAGE MILL RD
- **CITY:** PALO ALTO
- **STATE:** CA
- **BUSINESS PHONE:** (650) 223-7745

**MAIL ADDRESS:**
- **STREET 1:** 1891 PAGE MILL RD
- **CITY:** PALO ALTO
- **STATE:** CA
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001193125-26-161516

## Text-Extract

```

                                                           April 22, 2026

Luis Pe  a
Chief Executive Officer
Evommune, Inc.
1891 Page Mill Road
Palo Alto, CA 94304

       Re: Evommune, Inc.
           Registration Statement on Form S-1
           Filed April 17, 2026
           File No. 333-295140
Dear Luis Pe  a:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Tyler Howes at 202-551-3370 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Minkyu Park, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._